tiprankstipranks
Advertisement
Advertisement

ALKS Stock Latest News

Mizuho survey shows no consensus into Alkermes ADHD data
The FlyMizuho survey shows no consensus into Alkermes ADHD data
2d ago
ALKS
Trump Trade: U.S. considering new semiconductor tariffs
PremiumThe Fly
Trump Trade: U.S. considering new semiconductor tariffs
10d ago
MU
AMD
White House to announce drug pricing deals with biotechs, Bloomberg reports
PremiumThe Fly
White House to announce drug pricing deals with biotechs, Bloomberg reports
11d ago
ALKS
ALNY
Alkermes’ alixorexton featured in published Phase 2 study of narcolepsy
PremiumThe Fly
Alkermes’ alixorexton featured in published Phase 2 study of narcolepsy
13d ago
ALKS
Alkermes Amends Credit Agreement to Lower Borrowing Costs
PremiumCompany Announcements
Alkermes Amends Credit Agreement to Lower Borrowing Costs
25d ago
8K
ALKS
Alkermes Earnings Call Highlights Orexin-Fueled Growth
PremiumCompany AnnouncementsAlkermes Earnings Call Highlights Orexin-Fueled Growth
1M ago
ALKS
Alkermes: Solid Q2 and Promising Orexin-2 Pipeline, But Execution Risks Keep Rating at Hold and Price Target Unchanged at $43
Premium
Ratings
Alkermes: Solid Q2 and Promising Orexin-2 Pipeline, But Execution Risks Keep Rating at Hold and Price Target Unchanged at $43
1M ago
ALKS
Alkermes price target raised to $61 from $60 at JPMorgan
Premium
The Fly
Alkermes price target raised to $61 from $60 at JPMorgan
1M ago
ALKS
Alkermes price target raised to $58 from $48 at Baird
PremiumThe Fly
Alkermes price target raised to $58 from $48 at Baird
1M ago
ALKS
Alkermes sinks 5% to $50.05 following Q2 report
PremiumThe Fly
Alkermes sinks 5% to $50.05 following Q2 report
1M ago
ALKS
Alkermes reaffirms FY26 revenue view $1.73B-$1.84B, consensus $1.81B
PremiumThe Fly
Alkermes reaffirms FY26 revenue view $1.73B-$1.84B, consensus $1.81B
1M ago
ALKS
Alkermes reports Q2 revenue $496.0M, consensus $457.36M
PremiumThe Fly
Alkermes reports Q2 revenue $496.0M, consensus $457.36M
1M ago
ALKS
Alkermes reports Q2 EPS 0c, consensus 29c
PremiumThe FlyAlkermes reports Q2 EPS 0c, consensus 29c
1M ago
ALKS
Alkermes says Blair Jackson to assume CEO role on August 1
Premium
The Fly
Alkermes says Blair Jackson to assume CEO role on August 1
1M ago
ALKS
Alkermes price target raised to $65 from $43 at Piper Sandler
Premium
The Fly
Alkermes price target raised to $65 from $43 at Piper Sandler
1M ago
LLY
ALKS
Is ALKS a Buy, Before Earnings?
PremiumPre-Earnings
Is ALKS a Buy, Before Earnings?
1M ago
ALKS
Alkermes price target raised to $63 from $45 at Stifel
PremiumThe Fly
Alkermes price target raised to $63 from $45 at Stifel
2M ago
LLY
ALKS
American Express, Biogen upgraded: Wall Street’s top analyst calls
PremiumThe Fly
American Express, Biogen upgraded: Wall Street’s top analyst calls
2M ago
AXP
BBY
Thome Reiterates Buy on Encouraging Alixorexton Data and Reduced Oxybate Competition, Lifting Price Target to $57
PremiumRatings
Thome Reiterates Buy on Encouraging Alixorexton Data and Reduced Oxybate Competition, Lifting Price Target to $57
2M ago
ALKS
Alkermes announces results from planned interim analysis of LTE of alixorexton
PremiumThe FlyAlkermes announces results from planned interim analysis of LTE of alixorexton
2M ago
ALKS
Alkermes resumed with a Neutral at JPMorgan
Premium
The Fly
Alkermes resumed with a Neutral at JPMorgan
2M ago
ALKS
Alkermes Ends Generic VIVITROL Supply Agreement with Amneal
Premium
Company Announcements
Alkermes Ends Generic VIVITROL Supply Agreement with Amneal
2M ago
8K
ALKS

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >